OptiBiotix Health Plc (LON:OPTI – Get Free Report) insider David Blain bought 84,053 shares of the stock in a transaction on Wednesday, October 1st. The shares were acquired at an average cost of GBX 1,175 per share, for a total transaction of £987,622.75.
OptiBiotix Health Stock Performance
Shares of OPTI stock opened at GBX 11.02 on Friday. The business’s fifty day moving average is GBX 10.96 and its 200 day moving average is GBX 13.63. OptiBiotix Health Plc has a 52-week low of GBX 9 and a 52-week high of GBX 23.50. The company has a market capitalization of £11.39 million, a PE ratio of -599.02 and a beta of 1.71.
OptiBiotix Health (LON:OPTI – Get Free Report) last released its earnings results on Tuesday, September 16th. The company reported GBX (1.15) EPS for the quarter. OptiBiotix Health had a negative net margin of 524.43% and a negative return on equity of 36.76%.
About OptiBiotix Health
OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.
Read More
- Five stocks we like better than OptiBiotix Health
- Best Stocks Under $5.00
- General Dynamics Hits New Highs: Why It Might Keep Climbing
- What is Insider Trading? What You Can Learn from Insider Trading
- Nike’s Turnaround: If the Shoe Fits, Buy It!
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- NVIDIA Breaks Out to New Highs: What Comes Next?
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
